Thomas Michael Ruli Jr

Dr. Thomas Michael Ruli Jr


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 May 2024 in Cancers
Verified
Journal Article
Open access
PDF file
TJThomas Michael Ruli Jr
Thomas Michael Ruli Jr
EPEthan D. Pollack
Ethan D. Pollack
ALAtul Lodh
Atul Lodh
CICharles Evers III
Charles Evers III
CPChristopher A. Price
Christopher A. Price
MSMohamed Shoreibah
Mohamed Shoreibah
Primary liver cancer is one of the leading causes of cancer mortality worldwide, with hepatocellular carcinoma (HCC) being the most prevalent type of liver cancer. The prognosis of patients with advanced, unresectable HCC has historically been poor. However, with the emergence of immunotherapy, specifically immune checkpoint inhibitors (ICIs), there is reason for optimism. Nevertheless, ICIs do not come without risk, especially when administered in patients with HCC, given their potential underlying poor hepatic reserve. Given their novelty in the management of HCC, there are few studies to date specifically investigating ICI-related side effects on the liver in patients with underlying HCC. This review will serve as a guide for clinicians on ICIs’ role in the management of HCC and their potential side effect profile. There will be a discussion on ICI-related hepatotoxicity, the potential for hepatitis B and C reactivation with ICI use, the potential for the development of autoimmune hepatitis with ICI use, and the risk of gastrointestinal bleeding with ICI use. As ICIs become more commonplace as a treatment option in patients with advanced HCC, it is imperative that clinicians not only understand the mechanism of action of such agents but also understand and are able to identify hepatic-related side effects.

1 January 2024 in Clinical Liver Disease
Verified
Journal Article
Closed access
MAMahmoud Aryan
Mahmoud Aryan
TJThomas Michael Ruli Jr
Thomas Michael Ruli Jr
MSMohamed Shoreibah
Mohamed Shoreibah

26 December 2023 in American Journal of Gastroenterology
Verified
Journal Article
Closed access
TJThomas Michael Ruli Jr
Thomas Michael Ruli Jr
FWFrederick Weber
Frederick Weber
NBNicholas Baldwin
Nicholas Baldwin
An abstract is unavailable. This article is available as a PDF only.

24 April 2024 in American Journal of Gastroenterology
Verified
Journal Article
Closed access
TJThomas Michael Ruli Jr
Thomas Michael Ruli Jr
SPShajan Peter
Shajan Peter
DEDerek Estes
Derek Estes